Sfoglia per Autore
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study.
2018 Cerrito, M; De Giorgi, M; Pelizzoni, D; Bonomo, S; Digiacomo, N; Scagliotti, A; Bugarin, C; Gaipa, G; Grassilli, E; Lavitrano, M; Giovannoni, R; Bidoli, P; Cazzaniga, M
Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)
2018 Cazzaniga, M; Verusio, C; Ciccarese, M; Fumagalli, A; Sartori, D; Valerio, M; Airoldi, M; Moretti, G; Ficorella, C; Arcangeli, V; Diodati, L; Zambelli, A; Febbraro, A; Generali, D; Pistelli, M; Garrone, O; Musolino, A; Vici, P; Maur, M; Mentuccia, L; La Verde, N; Bianchi, G; Artale, S; Blasi, L; Piezzo, M; Atzori, F; Turletti, A; Benedetto, C; Cursano, M; Fabi, A; Gebbia, V; Schirone, A; Palumbo, R; Ferzi, A; Frassoldati, A; Scavelli, C; Clivio, L; Torri, V
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
2018 De Placido, S; Gallo, C; De Laurentiis, M; Bisagni, G; Arpino, G; Sarobba, M; Riccardi, F; Russo, A; Del Mastro, L; Cogoni, A; Cognetti, F; Gori, S; Foglietta, J; Frassoldati, A; Amoroso, D; Laudadio, L; Moscetti, L; Montemurro, F; Verusio, C; Bernardo, A; Lorusso, V; Gravina, A; Moretti, G; Lauria, R; Lai, A; Mocerino, C; Rizzo, S; Nuzzo, F; Carlini, P; Perrone, F; Accurso, A; Agostara, B; Aieta, M; Alabiso, O; Alicicco, M; Amadori, D; Amaducci, L; Amiconi, G; Antuzzi, G; Ardine, M; Ardizzoia, A; Aversa, C; Badalamenti, G; Barni, S; Basurto, C; Berardi, R; Bergamasco, C; Bidoli, P; Bighin, C; Biondi, E; Bisagni, G; Boni, C; Borgonovo, K; Botta, M; Bravi, S; Bruzzi, P; Buono, G; Butera, A; Caldara, A; Candeloro, G; Cappelletti, C; Cardalesi, C; Carfora, E; Cariello, A; Carrozza, F; Carteni, G; Caruso, M; Casadei, V; Casanova, C; Castori, L; Cavanna, L; Cavazzini, G; Cazzaniga, M; Chilelli, M; Chiodini, P; Chiorrini, S; Ciardiello, F; Ciccarese, M; Cinieri, S; Clerico, M; Coccaro, M; Comande, M; Corbo, C; Cortino, G; Cusenza, S; Daniele, G; D'Arco, A; D'Auria, G; Dazzi, C; De Angelis, C; de Braud, F; De Feo, G; De Matteis, A; De Tursi, M; Di Blasio, A; di Lucca, G; Di Lullo, L; Di Rella, F; Di Renzo, G; Di Stefano, P; Di Stefano, A; Diana, A; Donati, S; Fabbri, A; Fabi, A; Faedi, M; Farina, G; Farris, A; Febbraro, A; Fedele, P; Federico, P; Ferrau, F; Ferretti, G; Ferro, A; Floriani, I; Forcignano, R; Forciniti, S; Forestieri, V; Fornari, G; Frisinghelli, M; Fusco, V; Gallizzi, G; Galvano, A; Gambardella, A; Gambi, A; Gebbia, V; Gervasi, E; Ghilardi, M; Giacobino, A; Giardina, G; Giotta, F; Giraudi, S; Giuliano, M; Grassadonia, A; Grasso, D; Grosso, F; Guizzaro, L; Incoronato, P; Incorvaia, L; Iodice, G; La Verde, N; Labonia, V; Landi, G; Latorre, A; Leonardi, V; Levaggi, A; Limite, G; Lina Bascialla, L; Livi, L; Maiello, E; Mandelli, D; Marcon, I; Menon, D; Montedoro, M; Moraca, L; Moretti, A; Morritti, M; Morselli, P; Mura, A; Mura, S; Musacchio, M; Muzio, A; Natale, D; Natoli, C; Nigro, C; Nistico, C; Nuzzo, A; Orditura, M; Orlando, L; Pacilio, C; Palumbo, G; Palumbo, R; Pasini, F; Paterno, E; Pazzola, A; Pelliccioni, S; Pensabene, M; Perroni, D; Pesenti Gritti, A; Petrelli, F; Piccirillo, M; Pinotti, G; Pogliani, C; Poli, D; Prader, S; Recchia, F; Rizzi, D; Romano, C; Rossello, R; Rossini, C; Salvucci, G; Sanna, V; Santini, A; Saracchini, S; Savastano, C; Scambia, G; Schettini, F; Schiavone, P; Schirone, A; Seles, E; Signoriello, S; Signoriello, G; Silva, R; Silvestri, A; Simeon, V; Spagnoletti, I; Tamberi, S; Teragni, C; Thalmann, V; Thomas, R; Thomas, G; Tienghi, A; Tinari, N; Tinessa, V; Tomei, F; Tonini, G; Torri, V; Traficante, D; Tudini, M; Turazza, M; Vignoli, R; Vitale, M; Zacchia, A; Zagarese, P; Zanni, A; Zavallone, L; Zavettieri, M; Zoboli, A
Efficacy and safety of vinorelbine-capecitabine oral metronomic combinaton in elderly metastatc breast cancer patents: VICTOR-1 study
2017 Cazzaniga, M; Torri, V; Riva, F; Porcu, L; Cicchiello, F; Capici, S; Cortinovis, D; Digiacomo, N; Bidoli, P
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
2017 Gligorov, J; Ataseven, B; Verrill, M; de Laurentiis, M; Jung, K; Azim, H; Al-Sakaff, N; Lauer, S; Shing, M; Pivot, X; Koroveshi, D; Bouzid, K; Casalnuovo, M; Cascallar, D; Korbenfeld, E; Bastick, P; Beith, J; Colosimo, M; Friedlander, M; Ganju, V; Green, M; Patterson, K; Redfern, A; Richardson, G; Ceric, T; Gordana, K; Beato, C; Ferrari, M; Hegg, R; Helena, V; Ismael, G; Lessa, A; Mano, M; Morelle, A; Nogueira, J; Timcheva, K; Tomova, A; Tsakova, M; Zlatareva-Petrova, A; Asselah, J; Assi, H; Brezden-Masley, C; Chia, S; Freedman, O; Harb, M; Joy, A; Kulkarni, S; Prady, C; Gaete, A; Matamala, L; Torres, R; Yanez, E; Franco, S; Urrego, M; Gugic, D; Vrbanec, D; Melichar, B; Prausova, J; Vyzula, R; Pilarte, R; Leon, M; Munoz, R; Ramos, G; Azeem, H; Aziz, A; El Zawahry, H; Osegueda, F; Alexandre, J; Artignan, X; Barletta, H; Beguier, E; Berdah, J; Marty, C; Bollet, M; Bourgeois, H; Bressac, C; Burki, F; Campone, M; Coeffic, D; Cojocarasu, O; Dagada, C; Dalenc, F; Del Piano, F; Desauw, C; Desmoulins, I; Dohollou, N; Egreteau, J; Ferrero, J; Foa, C; Garidi, R; Gasnault, L; Guardiola, E; Hamizi, S; Jarcau, R; Jacquin, J; Jaubert, D; Jolimoy, G; Mineur, H; Largillier, R; Leduc, B; Martin, P; Melis, A; Monge, J; Moullet, I; Mousseau, M; Nguyen, S; Orfeuvre, H; Petit, T; Priou, F; Bach, I; Simon, H; Stefani, L; Uwer, L; Youssef, A; Aktas, B; von der Assen, A; Augustin, D; Balser, C; Bauer, L; Bechtner, C; Beyer, G; Brucker, C; Buckner, U; Busch, S; Christensen, B; Deryal, M; Farrokh, A; Faust, E; Friedrichs, K; Graf, H; Griesshammer, M; Grischke, E; Hanle, C; Heider, A; Henschen, S; Hesse, T; Jackisch, C; Kisro, J; Kohler, A; Kuemmel, S; Lampe, D; Lantzsch, T; Latos, K; Lex, B; Liedtke, C; Luedders, D; Maintz, C; Muller, V; Overkamp, F; Park-Simon, T; Paul, M; Prechtl, A; Ringsdorf, U; Runnebaum, I; Ruth, S; Salat, C; Scheffen, I; Schilling, J; Schmatloch, S; Schmidt, M; Schneeweiss, A; Schrader, I; Seipelt, G; Simon, E; Stefek, A; Stickeler, E; Thill, M; Tio, J; Tuczek, A; Warm, M; Weigel, M; Wischnik, A; Wojcinski, S; Ziegler-Lohr, K; Aravantinos, G; Ardavanis, A; Fountzilas, G; Gogas, H; Kakolyris, S; Mavroudis, D; Papadimitriou, C; Papandreou, C; Papazisis, K; Castro, H; Hernandez-Monroy, C; Ngan, R; Yeo, W; Bittner, N; Boer, K; Csejtei, A; Horvath, Z; Kocsis, J; Mangel, L; Mezei, K; Nagy, Z; Szanto, J; Atmakusuma, D; Fadjari, H; Kurnianda, D; Prayogo, N; Tanggo, E; Coate, L; Hennessy, B; Kelly, C; Martin, M; Nasim, S; O'Connor, M; Aieta, M; Allegrini, G; Amadori, D; Bidoli, P; Biti, G; Bordonaro, R; Bottini, A; Carterni, G; Cavanna, L; Cazzaniga, M; Cognetti, F; Contu, A; Cruciani, G; Donadio, M; Falcone, A; Farci, D; Forcignano, R; Frassoldati, A; Gaion, F; Gamucci, T; Giotta, F; Livi, L; Lorusso, V; Maiello, E; Marchetti, P; Mariani, G; Mion, M; Moscetti, L; Musolino, A; Pazzola, A; Pedrazzoli, P; Pigi, A; de Placido, S; Caremoli, E; Santoro, A; Tienghi, A; Ahn, J; Lee, K; Lee, S; Seo, J; Sohn, J; Cesas, A; Juozaityte, E; Cheah, N; Chong, F; Devi, B; Phua, V; Teoh, D; Ching, L; Yusof, M; Corona, J; Dominguez, A; Mendoza, R; Hernandez, C; Ramiro, A; Santos, J; Espinosa, P; Villarreal Garza, C; Errihani, H; Bakker, S; van den Berkmortel, F; Blaisse, R; Huinink, D; van den Bosch, J; Braun, J; Dercksen, M; Droogendijk, H; Erdkamp, F; Haringhuizen, A; de Jongh, F; Kok, T; Los, M; Madretsma, S; Terwogt, J; van der Padt, A; van Rossum-Schornagel, Q; Smilde, T; de Valk, B; van der Velden, A; van Warmerdam, L; van de Wouw, A; North, R; Kersten, C; Mjaaland, I; Wist, E; Aziz, Z; Masood, N; Rashid, K; Shah, M; Alcedo, J; Aleman, D; Neciosup, S; Reategui, R; Valdiviezo, N; Vera, L; Fernando, G; Roque, F; Strebel, H; Krzemieniecki, K; Litwiniuk, M; Mruk, A; Pienkowski, T; Sawrycki, P; Slomian, G; Tomczak, P; Afonso, N; Cardoso, F; Damasceno, M; Nave, M; Badulescu, F; Ciule, L; Curescu, S; Eniu, A; Filip, D; Grecea, D; Jinga, D; Lungulescu, D; Oprean, C; Stanculeanu, D; Turdean, M; Dvornichenko, V; Emelyanov, S; Lichinitser, M; Manikhas, A; Sakaeva, D; Shirinkin, V; Stroyakovskiy, D; Abulkhair, O; Zekri, J; Filipovic, S; Kovcin, V; Nedovic, J; Pesic, J; Vasovic, S; Ng, R; Bystricky, B; Leskova, J; Mardiak, J; Misurova, E; Wagnerova, M; Takac, I; Demetriou, G; Dreosti, L; Govender, P; Jordaan, J; Veersamy, P; Romero, J; Lopez, N; Arias, C; Chacon, J; Aramburo, A; Morales, L; Garcia, M; Estevez, L; Garcia-Palomo Perez, A; Garcia Saenz, J; Garcia Sanchis, L; Cubells, L; Cortijo, L; Santiago, S; De Aranguiz, B; Manas, J; Gallego, P; Cussac, A; Ferrandiz, C; Garrido, M; Alvarez, P; Vega, J; Del Prado, P; Janez, N; Murillo, S; Rosales, A; Jaso, L; Fernandez, I; Martorell, A; Carrion, R; Simon, S; Alcibar, A; Lorenzo, J; Garcia, V; Asensio, T; Maicas, M; Villanueva Silva, M; Killander, F; Svensson, J; Fehr, M; Hauser, N; Muller, A; Pagani, O; Passmann-Kegel, H; Popescu, R; Rabaglio, M; Rauch, D; Schlatter, C; Zaman, K; Chang, T; Huang, C; Wang, H; Yu, J; Bandidwattanawong, C; Maneechavakajorn, J; Seetalarom, K; Dejthevaporn, T; Somwangprasert, A; Vongsaisuwon, M; Akbulut, H; Altundag, K; Arican, A; Bozcuk, H; Eralp, Y; Idris, M; Isikdogan, A; Senol, C; Sevinc, A; Uygun, K; Yucel, E; Yucel, I; Yumuk, F; Shparyk, Y; Voitko, N; Jaloudi, M; Adams, J; Agrawal, R; Ahmed, S; Alhasso, A; Allerton, R; Anwar, S; Archer, C; Ashford, R; Barraclough, L; Bertelli, G; Bishop, J; Branson, T; Butt, M; Chakrabarti, A; Chakraborti, P; Churn, M; Crowley, C; Davis, R; Dhadda, A; Eldeeb, H; Fraser, J; Hall, J; Hickish, T; Hogg, M; Howe, T; Joffe, J; Kelleher, M; Kelly, S; Kendall, A; Kristeleit, H; Lumsden, G; Macmillan, C; Macpherson, I; Malik, Z; Mithal, N; Neal, A; Panwar, U; Proctor, A; Proctor, S; Raj, S; Rehman, S; Sandri, I; Scatchard, K; Sherwin, E; Sims, E; Singer, J; Smith, S; Tahir, S; Taylor, W; Tsalic, M; Wardley, A; Waters, S; Wheatley, D; Wright, K; Yuille, F; Alonso, I; Artagaveytia, N; Rodriguez, R; Arbona, E; Garcia, Y; Lion, L; Marcano, D; Van Thuan, T
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)
2017 Kieffer, J; Postma, T; van de Poll Franse, L; Mols, F; Heimans, J; Cavaletti, G; Aaronson, N; Cavaletti, G; Cornblath, D; Merkies, I; Postma, T; Valsecchi, M; Galimberti, S; Rossi, E; Cavaletti, G; Frigeni, B; Lanzani, F; Mattavelli, L; Piatti, M; Alberti, P; Binda, D; Bidoli, P; Cazzaniga, M; Cortinovis, D; Bruna, J; Velasco, R; Argyriou, A; Kalofonos, H; Psimaras, D; Ricard, D; Pace, A; Galiã¨, E; Briani, C; Lucchetta, M; Campagnolo, M; Torre, C; Faber, C; Merkies, I; Vanhoutte, E; Bakkers, M; Brouwer, B; Boogerd, M; Lalisang, R; Boogerd, W; Brandsma, D; Koeppen, S; Hense, J; Grant, R; Storey, D; Kerrigan, S; Schenone, A; Reni, L; Piras, B; Fabbri, S; Pessino, A; Padua, L; Granata, G; Leandri, M; Ghignotti, I; Plasmati, R; Pastorelli, F; Postma, T; Heimans, J; Eurelings, M; Meijer, R; Grisold, W; Pozza, E; Mazzeo, A; Toscano, A; Russo, M; Tomasello, C; Altavilla, G; Prado, M; Gonzalez, C; Dorsey, S
Everolimus plus exemestane in advanced breast cancer: Safety results of the BALLET study on patients previously treatedwithout and with chemotherapy in the metastatic setting
2017 Generali, D; Montemurro, F; Bordonaro, R; Mafodda, A; Romito, S; Michelotti, A; Piovano, P; Ionta, M; Bighin, C; Sartori, D; Frassoldati, A; Cazzaniga, M; Riccardi, F; Testore, F; Vici, P; Barone, C; Schirone, A; Piacentini, F; Nolè, F; Molino, A; Latini, L; Simoncini, E; Roila, F; Cognetti, F; Nuzzo, F; Foglietta, J; Minisini, A; Goffredo, F; Portera, G; Ascione, G; Mariani, G; Cazzaniga, M; Contributor,
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
2017 Cazzaniga, M; Cortesi, L; Ferzi, A; Scaltriti, L; Cicchiello, F; Ciccarese, M; Torre, S; Villa, F; Giordano, M; Verusio, C; Nicolini, M; Gambaro, A; Zanlorenzi, L; Biraghi, E; Casini, E; Legramandi, L; Rulli, E
Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials
2017 Bernardo, A; Palumbo, R; Pedersini, R; Rota Caremoli, E; Gambaro, A; Ferzi, A; Riva, F; Grasso, D; Danova, M; Tarenzi, E; Torri, V; Cazzaniga, M
Metronomic chemotherapy for advanced breast cancer patients
2017 Cazzaniga, M; Dionisio, M; Riva, F
Fulvestrant (FUL) as first-line therapy in HR+ve, HER2-ve advanced breast cancer (ABC) patients (pts): when clinical practice comes earlier than clinical trials. Results from the GIM-13 AMBRA study
2017 Pronzato, P; Mustacchi, G; Riccardi, F; Turletti, A; Michelotti, A; Natoli, C; Livi, L; Del Mastro, L; Donadio, M; Garrone, O; Giordano, M; De Laurentiis, M; Marchetti, P; Montemurro, F; Romagnoli, E; De Placido, S; Biganzoli, L; Cazzaniga, M
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study
2017 Cicchiello, F; Riva, F; Cazzaniga, M; Pedani, F; Nicolini, M; Butti, C; Liscia, N; Pogliani, C; Capri, G; Alu, M; Febbraro, A; Petrucelli, L; D'Onofrio, L; De Laurentiis, M; Pellegrini, D; Mentuccia, L; Cocciolone, V; Miraglio, E; Bajardi, E; Dester, M; Paterno, E; Guaitoli, G; Ferrarini, I; Gervasi, E; Licata, L; Benedetto, C; Andreis, D; Bordin, E; Ancona, C; Pizzuti, L; Fotia, V; Berardi, R; Airoldi, M; Arcangeli, V; Artale, S; Atzori, F; Ballerio, A; Bianchi, G; Blasi, L; Campidoglio, S; Ciccarese, M; Cursano, M; Piezzo, M; Fabi, A; Ferrari, L; Ferzi, A; Ficorella, C; Frassoldati, A; Fumagalli, A; Garrone, O; Gebbia, V; Generali, D; La Verde, N; Maur, M; Michelotti, A; Moretti, G; Musolino, A; Palumbo, R; Pistelli, M; Porpiglia, M; Sartori, D; Scavelli, C; Schirone, A; Turletti, A; Valerio, M; Vici, P; Zambelli, A; Clivio, L; Torri, V
In reply to Kadri Altundag
2017 Cazzaniga, M
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience
2017 Ciccarese, M; Fabi, A; Moscetti, L; Cazzaniga, M; Petrucelli, L; Forcignanò, R; Lupo, L; De Matteis, E; Chiuri, V; Cairo, G; Febbraro, A; Giordano, G; Giampaglia, M; Bilancia, D; La Verde, N; Maiello, E; Morritti, M; Giotta, F; Lorusso, V; Latorre, A; Scavelli, C; Romito, S; Cusmai, A; Palmiotti, G; Surico,
A Multidisciplinary Intervention to Tell Children about the Parent's Cancer: Preliminary Results
2016 Jankovic, M; Gallina, F; Ripamonti, C; Cazzaniga, M; Bani, M; Mazza, U
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]]
2016 Arpino, G; Generali, D; Sapino, A; Del Mastro, L; Frassoldati, A; de Laurentiis, M; Pronzato, P; Mustacchi, G; Cazzaniga, M; De Placido, S; Conte, P; Cappelletti, M; Zanoni, V; Antonelli, A; Martinotti, M; Puglisi, F; Berruti, A; Bottini, A; Dogliotti, L
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: Current status and future development
2016 Cazzaniga, M; Camerini, A; Addeo, R; Nolè, F; Munzone, E; Collovà, E; Del Conte, A; Mencoboni, M; Papaldo, P; Pasini, F; Saracchini, S; Bocci, G
Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
2016 Cazzaniga, M; Cortesi, L; Ferzi, A; Scaltriti, L; Cicchiello, F; Ciccarese M, M; Della Torre, S; Villa, F; Giordano, M; Verusio, C; Nicolini, M; Gambaro, A; Zanlorenzi, L; Biraghi, E; Legramandi, L; Rulli, E
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study
2016 Arpino, G; Michelotti, A; Truini, M; Montemurro, F; Russo, S; Palumbo, R; Zamagni, C; Latorre, A; Bruzzese, D; Riccardi, F; De Laurentiis, M; Beano, A; Biganzoli, L; Zaniboni, A; Laudadio, L; Malagoli, M; Bilancia, D; Schettini, F; Giuliano, M; Cazzaniga, M; De Placido, S
Everolimus-based therapy in patients with hormone receptor-positive, HER2- advanced breast cancer: Management considerations
2015 Del Mastro, L; Cazzaniga, M; Solidoro, P; Generali, D; Bianchi, G; Testore, F; De Placido, S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile